Skip to main content

Table 1 Clinicopathological characteristics of 583 patients treated with chemoradiotherapy

From: Risk factors associated with fatal pulmonary hemorrhage in locally advanced non-small cell lung cancer treated with chemoradiotherapy

Characteristics

 

No. of patients (%)

Overall number

583

Age (years)

median (range)

65 (31-85)

 

≤ 70

449 (77.0)

 

> 70

134 (23.0)

Gender

 
 

Male

482 (82.7)

 

Female

101 (17.3)

ECOG PS

 
 

0

171 (29.3)

 

1

408 (70.0)

 

2

4 (0.7)

Smoking history

 
 

Nonsmoker

51 (8.7)

 

Ever-smoker

532 (91.3)

Stage

  
 

IIA

6 (1.0)

 

IIB

24 (4.1)

 

IIIA

209 (35.8)

 

IIIB

344 (59.0)

Histology

 
 

Adenocarcinoma

275 (47.2)

 

Squamous cell carcinoma

208 (35.7)

 

NSCLC

98 (16.8)

Fatal pulmonary hemorrhage

  
 

Absent

571 (97.9)

 

Present

12 (2.1)

Tumor loction

 
 

Central

127 (21.8)

 

Peripheral

456 (78.2)

Tumor laterality

 
 

Right

346 (59.3)

 

Left

236 (40.5)

Baseline tumor cavitation

 
 

Absent

545 (93.5)

 

Present

38 (6.5)

Baseline cough

 
 

Absent

317 (54.4)

 

Present

266 (45.6)

Baseline chest pain

 
 

Absent

484 (83.0)

 

Present

99 (17.0)

Baseline sputum

 
 

Absent

454 (77.9)

 

Present

129 (22.1)

Baseline hoarseness

 
 

Absent

536 (91.9)

 

Present

47 (8.1)

Baseline hemoptysis

  
 

Absent

468 (80.3)

 

Present

115 (19.7)

  1. ECOG PS: Eastern Cooperative Oncology Group Performance Status, NSCLC: non-small cell lung cancer